B-cell lymphoma/leukaemia 10 and angiotensin II-induced kidney injury.


Journal

Cardiovascular research
ISSN: 1755-3245
Titre abrégé: Cardiovasc Res
Pays: England
ID NLM: 0077427

Informations de publication

Date de publication:
01 04 2020
Historique:
received: 07 06 2018
revised: 09 01 2019
accepted: 21 06 2019
pubmed: 27 6 2019
medline: 21 10 2020
entrez: 27 6 2019
Statut: ppublish

Résumé

B-cell lymphoma/leukaemia 10 (Bcl10) is a member of the CARMA-Bcl10-MALT1 signalosome, linking angiotensin (Ang) II, and antigen-dependent immune-cell activation to nuclear factor kappa-B signalling. We showed earlier that Bcl10 plays a role in Ang II-induced cardiac fibrosis and remodelling, independent of blood pressure. We now investigated the role of Bcl10 in Ang II-induced renal damage. Bcl10 knockout mice (Bcl10 KO) and wild-type (WT) controls were given 1% NaCl in the drinking water and Ang II (1.44 mg/kg/day) for 14 days. Additionally, Bcl10 KO or WT kidneys were transplanted onto WT mice that were challenged by the same protocol for 7 days. Kidneys of Ang II-treated Bcl10 KO mice developed less fibrosis and showed fewer infiltrating cells. Nevertheless, neutrophil gelatinase-associated lipocalin (Ngal) and kidney injury molecule (Kim)1 expression was higher in the kidneys of Ang II-treated Bcl10 KO mice, indicating exacerbated tubular damage. Furthermore, albuminuria was significantly higher in Ang II-treated Bcl10 KO mice accompanied by reduced glomerular nephrin expression and podocyte number. Ang II-treated WT mice transplanted with Bcl10 KO kidney showed more albuminuria and renal Ngal, compared to WT- > WT kidney-transplanted mice, as well as lower podocyte number but similar fibrosis and cell infiltration. Interestingly, mice lacking Bcl10 in the kidney exhibited less Ang II-induced cardiac hypertrophy than controls. Bcl10 has multi-faceted actions in Ang II-induced renal damage. On the one hand, global Bcl10 deficiency ameliorates renal fibrosis and cell infiltration; on the other hand, lack of renal Bcl10 aggravates albuminuria and podocyte damage. These data suggest that Bcl10 maintains podocyte integrity and renal function.

Identifiants

pubmed: 31241148
pii: 5523185
doi: 10.1093/cvr/cvz169
doi:

Substances chimiques

B-Cell CLL-Lymphoma 10 Protein 0
Bcl10 protein, mouse 0
Havcr1 protein, mouse 0
Hepatitis A Virus Cellular Receptor 1 0
Lipocalin-2 0
Membrane Proteins 0
nephrin 0
Angiotensin II 11128-99-7
Lcn2 protein, mouse 126469-30-5

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1059-1070

Commentaires et corrections

Type : CommentIn

Informations de copyright

Published on behalf of the European Society of Cardiology. All rights reserved. © The Author(s) 2019. For permissions, please email: journals.permissions@oup.com.

Auteurs

Lajos Markó (L)

Experimental and Clinical Research Center, a cooperation of Charité - Universitätsmedizin Berlin, Berlin, Germany and Max Delbrück Center for Molecular Medicine, 13125 Berlin, Germany.
DZHK (German Centre for Cardiovascular Research), Partner Site, Berlin, Germany.
Berlin Institute of Health (BIH), Berlin, Germany.
Charité-Universitätsmedizin Berlin, Berlin, Germany.

Joon-Keun Park (JK)

Hannover Medical School, Hannover, Germany.

Norbert Henke (N)

Helios Clinic Damp, Berlin, Germany.

Song Rong (S)

Hannover Medical School, Hannover, Germany.
Transplantation Center, Zunyi Medical College, Zunyi, China.

András Balogh (A)

Experimental and Clinical Research Center, a cooperation of Charité - Universitätsmedizin Berlin, Berlin, Germany and Max Delbrück Center for Molecular Medicine, 13125 Berlin, Germany.
DZHK (German Centre for Cardiovascular Research), Partner Site, Berlin, Germany.
Berlin Institute of Health (BIH), Berlin, Germany.
Charité-Universitätsmedizin Berlin, Berlin, Germany.

Samuel Klamer (S)

Experimental and Clinical Research Center, a cooperation of Charité - Universitätsmedizin Berlin, Berlin, Germany and Max Delbrück Center for Molecular Medicine, 13125 Berlin, Germany.

Hendrik Bartolomaeus (H)

Experimental and Clinical Research Center, a cooperation of Charité - Universitätsmedizin Berlin, Berlin, Germany and Max Delbrück Center for Molecular Medicine, 13125 Berlin, Germany.
DZHK (German Centre for Cardiovascular Research), Partner Site, Berlin, Germany.
Berlin Institute of Health (BIH), Berlin, Germany.
Charité-Universitätsmedizin Berlin, Berlin, Germany.
Max-Delbrück Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany.

Nicola Wilck (N)

Experimental and Clinical Research Center, a cooperation of Charité - Universitätsmedizin Berlin, Berlin, Germany and Max Delbrück Center for Molecular Medicine, 13125 Berlin, Germany.
DZHK (German Centre for Cardiovascular Research), Partner Site, Berlin, Germany.
Berlin Institute of Health (BIH), Berlin, Germany.
Charité-Universitätsmedizin Berlin, Berlin, Germany.

Jürgen Ruland (J)

Institute of Clinical Chemistry and Pathobiochemistry, School of Medicine, Technical University of Munich, Munich, Germany.
Center for Translational Cancer Research (TranslaTUM), Munich, Germany.
German Cancer Consortium (DKTK), partner Site, Munich, Germany.

Sofia K Forslund (SK)

Experimental and Clinical Research Center, a cooperation of Charité - Universitätsmedizin Berlin, Berlin, Germany and Max Delbrück Center for Molecular Medicine, 13125 Berlin, Germany.
DZHK (German Centre for Cardiovascular Research), Partner Site, Berlin, Germany.
Berlin Institute of Health (BIH), Berlin, Germany.
Charité-Universitätsmedizin Berlin, Berlin, Germany.
Max-Delbrück Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany.

Friedrich C Luft (FC)

Experimental and Clinical Research Center, a cooperation of Charité - Universitätsmedizin Berlin, Berlin, Germany and Max Delbrück Center for Molecular Medicine, 13125 Berlin, Germany.
Max-Delbrück Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany.

Ralf Dechend (R)

Experimental and Clinical Research Center, a cooperation of Charité - Universitätsmedizin Berlin, Berlin, Germany and Max Delbrück Center for Molecular Medicine, 13125 Berlin, Germany.
DZHK (German Centre for Cardiovascular Research), Partner Site, Berlin, Germany.
Berlin Institute of Health (BIH), Berlin, Germany.
Charité-Universitätsmedizin Berlin, Berlin, Germany.
Helios Clinic Berlin-Buch, Berlin, Germany.

Dominik N Müller (DN)

Experimental and Clinical Research Center, a cooperation of Charité - Universitätsmedizin Berlin, Berlin, Germany and Max Delbrück Center for Molecular Medicine, 13125 Berlin, Germany.
DZHK (German Centre for Cardiovascular Research), Partner Site, Berlin, Germany.
Berlin Institute of Health (BIH), Berlin, Germany.
Charité-Universitätsmedizin Berlin, Berlin, Germany.
Max-Delbrück Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany.

Articles similaires

Humans Meals Time Factors Female Adult

Vancomycin-associated DRESS demonstrates delay in AST abnormalities.

Ahmed Hussein, Kateri L Schoettinger, Jourdan Hydol-Smith et al.
1.00
Humans Drug Hypersensitivity Syndrome Vancomycin Female Male
Robotic Surgical Procedures Animals Humans Telemedicine Models, Animal

Odour generalisation and detection dog training.

Lyn Caldicott, Thomas W Pike, Helen E Zulch et al.
1.00
Animals Odorants Dogs Generalization, Psychological Smell

Classifications MeSH